|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
2
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar
|
|
3
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar
|
|
4
|
Phan LM, Yeung SC and Lee MH: Cancer
metabolic reprogramming: Importance, main features, and potentials
for precise targeted anti-cancer therapies. Cancer Biol Med.
11:1–19. 2014.
|
|
5
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar
|
|
6
|
Lincet H and Icard P: How do glycolytic
enzymes favour cancer cell proliferation by nonmetabolic functions.
Oncogene. 34:3751–3759. 2015. View Article : Google Scholar
|
|
7
|
Han T, Kang D, Ji D, Wang X, Zhan W, Fu M,
Xin HB and Wang JB: How does cancer cell metabolism affect tumor
migration and invasion. Cell Adhes Migr. 7:395–403. 2013.
View Article : Google Scholar
|
|
8
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar
|
|
9
|
Lee JT: Epigenetic regulation by long
noncoding RNAs. Science. 338:1435–1439. 2012. View Article : Google Scholar
|
|
10
|
Taylor DH, Chu ET, Spektor R and Soloway
PD: Long non-coding RNA regulation of reproduction and development.
Mol Reprod Dev. 82:932–956. 2015. View Article : Google Scholar
|
|
11
|
Zhu X, Wu YB, Zhou J and Kang DM:
Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via
increasing FoxO1 expression. Biochem Biophys Res Commun.
469:319–325. 2016. View Article : Google Scholar
|
|
12
|
Qi M, Zhou Q, Zeng W, Shen M, Liu X, Luo
C, Long J, Chen W, Zhang J and Yan S: Analysis of long non-coding
RNA expression of lymphatic endothelial cells in response to type 2
diabetes. Cell Physiol Biochem. 41:466–474. 2017. View Article : Google Scholar
|
|
13
|
Yang Y, Chen L, Gu J, Zhang H, Yuan J,
Lian Q, Lv G, Wang S, Wu Y, Yang YT, et al: Recurrently deregulated
lncRNAs in hepatocellular carcinoma. Nat Commun. 8:144212017.
View Article : Google Scholar
|
|
14
|
Chureau C, Chantalat S, Romito A, Galvani
A, Duret L, Avner P and Rougeulle C: Ftx is a non-coding RNA which
affects Xist expression and chromatin structure within the
X-inactivation center region. Hum Mol Genet. 20:705–718. 2011.
View Article : Google Scholar
|
|
15
|
Liu Z, Dou C, Yao B, Xu M, Ding L, Wang Y,
Jia Y, Li Q, Zhang H, Tu K, et al: Ftx non coding RNA-derived
miR-545 promotes cell proliferation by targeting RIG-I in
hepatocellular carcinoma. Oncotarget. 7:25350–25365. 2016.
|
|
16
|
Patitucci C, Couchy G, Bagattin A, Cañeque
T, de Reyniès A, Scoazec JY, Rodriguez R, Pontoglio M, Zucman-Rossi
J, Pende M, et al: Hepatocyte nuclear factor 1α suppresses
steatosis-associated liver cancer by inhibiting PPARγ
transcription. J Clin Invest. 127:1873–1888. 2017. View Article : Google Scholar
|
|
17
|
Janani C and Ranjitha Kumari BD: PPAR
gamma gene - a review. Diabetes Metab Syndr. 9:46–50. 2015.
View Article : Google Scholar
|
|
18
|
Wu Z, Xie Y, Morrison RF, Bucher N and
Farmer SR: PPARgamma induces the insulin-dependent glucose
transporter GLUT4 in the absence of C/EBPalpha during the
conversion of 3T3 fibroblasts into adipocytes. J Clin Invest.
101:22–32. 1998. View
Article : Google Scholar
|
|
19
|
Lecarpentier Y, Claes V, Vallée A and
Hébert JL: Thermodynamics in cancers: Opposing interactions between
PPAR gamma and the canonical WNT/beta-catenin pathway. Clin Transl
Med. 6:142017. View Article : Google Scholar
|
|
20
|
Rangwala SM and Lazar MA: Peroxisome
proliferator-activated receptor gamma in diabetes and metabolism.
Trends Pharmacol Sci. 25:331–336. 2004. View Article : Google Scholar
|
|
21
|
Chen R, Zhu D, Ye X, Shen D and Lu R:
Establishment of three human liver carcinoma cell lines and some of
their biological characteristics in vitro. Sci Sin. 23:236–247.
1980.
|
|
22
|
Nakabayashi H, Taketa K, Miyano K, Yamane
T and Sato J: Growth of human hepatoma cells lines with
differentiated functions in chemically defined medium. Cancer Res.
42:3858–3863. 1982.
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Ferreira LM: Cancer metabolism: The
Warburg effect today. Exp Mol Pathol. 89:372–380. 2010. View Article : Google Scholar
|
|
25
|
Adekola K, Rosen ST and Shanmugam M:
Glucose transporters in cancer metabolism. Curr Opin Oncol.
24:650–654. 2012. View Article : Google Scholar
|
|
26
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar
|
|
27
|
Klingenberg M, Matsuda A, Diederichs S and
Patel T: Non-coding RNA in hepatocellular carcinoma: Mechanisms,
biomarkers and therapeutic targets. J Hepatol. 67:603–618. 2017.
View Article : Google Scholar
|
|
28
|
Zhao Q, Li T, Qi J, Liu J and Qin C: The
miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in
HBV-related hepatocellular carcinoma and promotes tumorigenesis and
tumor progression. PLoS One. 9:e1097822014. View Article : Google Scholar
|
|
29
|
Iansante V, Choy PM, Fung SW, Liu Y, Chai
JG, Dyson J, Del Rio A, D'Santos C, Williams R, Chokshi S, et al:
ARP14 promotes the Warburg effect in hepatocellular carcinoma by
inhibiting JNK1-dependent PKM2 phosphorylation and activation. Nat
Commun. 6:78822015. View Article : Google Scholar
|
|
30
|
Zhang P, Cao L, Fan P, Mei Y and Wu M:
LncRNA-MIF, a c-Myc-activated long non-coding RNA, suppresses
glycolysis by promoting Fbxw7-mediated c-Myc degradation. EMBO Rep.
17:1204–1220. 2016. View Article : Google Scholar
|
|
31
|
Li Z, Li X, Wu S, Xue M and Chen W: Long
non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase
2 through the mTOR-STAT3/microRNA143 pathway. Cancer Sci.
105:951–955. 2014. View Article : Google Scholar
|
|
32
|
Hamanaka RB and Chandel NS: Targeting
glucose metabolism for cancer therapy. J Exp Med. 209:211–215.
2012. View Article : Google Scholar
|
|
33
|
Long B, Li N, Xu XX, Li XX, Xu XJ, Guo D,
Zhang D, Wu ZH and Zhang SY: Long noncoding RNA FTX regulates
cardiomyocyte apoptosis by targeting miR-29b-1-5p and Bcl2l2.
Biochem Biophys Res Commun. 495:312–318. 2018. View Article : Google Scholar
|
|
34
|
Zhang W, Bi Y, Li J, Peng F, Li H, Li C,
Wang L, Ren F, Xie C, Wang P, et al: Long noncoding RNA FTX is
upregulated in gliomas and promotes proliferation and invasion of
glioma cells by negatively regulating miR-342-3p. Lab Invest.
97:447–457. 2017. View Article : Google Scholar
|
|
35
|
Guo XB, Hua Z, Li C, Peng LP, Wang JS,
Wang B and Zhi QM: Biological significance of long non-coding RNA
FTX expression in human colorectal cancer. Int J Clin Exp Med.
8:15591–15600. 2015.
|
|
36
|
He X, Sun F, Guo F, Wang K, Gao Y, Feng Y,
Song B, Li W and Li Y: Knockdown of long noncoding RNA FTX inhibits
proliferation, migration, and invasion in renal cell carcinoma
cells. Oncol Res. 25:157–166. 2017. View Article : Google Scholar
|
